29,026 resources
By Version
By Authority
By Realm
Start Prev Rows 16600 - 16800 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth | Source(s) |
---|---|---|---|---|---|---|---|---|---|---|
tw.gov.mohw.cdc.twidir | R4 | loinc-observation-category | LOINC實驗室檢驗檢查類型值集 | draft | 2023-08 | tw | national | loinc | ||
tw.gov.mohw.twcore | R4 | vital-signs-tw | LOINC生命體徵值集 | active | 2022-08 | tw | national | loinc | ||
tw.gov.mohw.twcore | R4 | loinc-survey-codes | LOINC篩檢與評估值集 | active | 2025-05 | tw | national | loinc | ||
tw.cathay.fhir.imri | R4 | loinc-observation-clinical-code | LOINC臨床分類值集 | active | 2024-05 | tw | loinc | |||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.635 | LP(a) Test_ICD | active | 2025-03 | us | hl7 | icd | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7755 | LTBI Drug Regimen (TB) | active | 2018-01 | us | tho oid | |||
ans.fr.nos | R4 | JDV-J177-BesoinAideMobilite-MDPH | JDV_J177-BesoinAideMobilite-MDPH | active | 2021-09 | fr | national | |||
MyHIE.v4-test | R4 | value-set-task-status-lab-my-core | ValueSetTaskStatusLab (MY Core) | active | 2023-03 | fhir | ||||
IdHIE.0v | R4 | value-set-task-status-lab-id-core | ValueSetTaskStatusLab (ID Core) | active | 2023-06 | fhir | ||||
MyHIE.v4-test | R4 | value-set-lab-sub-group-my-core | ValueSetLabSubGroup (MY Core) | active | 2023-01 | |||||
IdHIE.0v | R4 | value-set-lab-sub-group-id-core | ValueSetLabSubGroup (ID Core) | active | 2023-06 | |||||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7866 | Lab Test Method (MDRO) | active | 2019-01 | us | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3358 | Lab Test Name (NND) | active | 2010-01 | us | loinc | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7278 | Lab Test Performed Modifier (CS) | active | 2016-01 | us | oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3017 | Lab Test Result (PHLIP Flu) | active | 2019-01 | us | nucc sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.6013 | Lab Test Type (Hepatitis) | active | 2022-01 | us | loinc | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.6014 | Lab Test Type Enzymes (Hepatitis) | active | 2012-01 | us | loinc | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3016 | Lab Test Order (PHLIP Flu) | active | 2019-01 | us | oid loinc | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.4275 | Lab Result (Cancer Morphology) | active | 2011-01 | us | sct | |||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.50 | MSI High | active | 2023-11 | us | hl7 | sct | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7892 | Lab Result (Candida auris) | active | 2019-01 | us | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7895 | Lab Result Carbapenem Resistant Enterobacteriace | active | 2019-01 | us | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.4024 | Lab Result (Cysticercosis) | active | 2019-01 | us | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.4067 | Lab Result (Nontuberculous Mycobacteria) | active | 2019-01 | us | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.4276 | Lab Result (Pesticide) | active | 2011-01 | us | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7894 | Lab Test Name (Candida Auris) | active | 2019-01 | us | loinc | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7893 | Lab Test Name Carbapenem Resistant Enterobacteria | active | 2019-01 | us | loinc | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8030 | Lab Test (Hansen) | active | 2021-01 | us | sct tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7733 | Lab Test Method (RIBD) | active | 2019-01 | us | tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1004 | Ordered Test | active | 2020-01 | us | loinc | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7472 | Lab Test Type (Arbovirus) | active | 2018-01 | us | oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8041 | Lab Test Type (Leptospirosis) | active | 2021-01 | us | sct tho oid | |||
incisive.fhir | R4 | LabelCodes | Label Codes | active | 2023-07 | |||||
ca.on.oh-olis | R4 | olis-RequestTiming | RequestTiming | active | hl7 | |||||
ca.on.ehr.r4 | R4 | ValueSet-ReportableTestIndicator | Reportable Test Indicator EHR | active | 2025-04 | ca | national | |||
ca.on.oh-olis | R4 | olis-ReportableTestIndicator | ReportableTestIndicator | active | hl7 | |||||
hl7.fhir.us.core | R4 | us-core-laboratory-test-codes | US Core Laboratory Test Codes | trial-use | 3 | cgp | 2022-11 | us | hl7 | loinc |
fhir.cdc.opioid-cds-r4 | R4 | observation-category-laboratory | Observation Category Laboratory | active | 2023-05 | us | hl7 | |||
myhealth.eu.fhir.laboratory | R4 | eHDSIPerformerFunction | eHDSI Performer Function | trial-use | 2 | 2025-03 | eu | tho | ||
hl7.fhir.uv.lab-report | R4 | reportBundleType-uv-lab | Laboratory Report Bundle Types | trial-use | 2 | oo | 2025-01 | uv | hl7 | fhir |
hl7.fhir.uv.lab-report | R4 | reportType-uv-lab | Laboratory Report Types | trial-use | 2 | oo | 2025-01 | uv | hl7 | loinc |
hl7.fhir.eu.laboratory | R4 | lab-reportType-eu-lab | Laboratory Report Types | trial-use | 2 | 2025-07 | eu | hl7 | loinc | |
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1002 | Lab Test Result Name | active | 2020-01 | us | loinc | |||
ch.fhir.ig.ch-vacd | R4 | ch-vacd-laboratory-serology-vs | Laboratory Serology for Immunization | active | 2025-05 | ch | hl7 | loinc | ||
hl7.fhir.uv.lab-report | R4 | specialty-uv-lab | Laboratory Specialty | trial-use | 2 | oo | 2025-01 | uv | hl7 | sct |
hl7.fhir.eu.laboratory | R4 | lab-specialty-eu-lab | Laboratory Specialty | trial-use | 2 | 2025-07 | eu | hl7 | sct | |
hl7.fhir.uv.lab-report | R4 | specimenType-uv-lab | Specimen Types | trial-use | 2 | oo | 2025-01 | uv | hl7 | sct |
hl7.fhir.eu.laboratory | R4 | lab-specimenType-eu-lab | Specimen Types | trial-use | 2 | 2025-07 | eu | hl7 | sct | |
hl7.fhir.uv.lab-report | R4 | studyType-uv-lab | Laboratory Study Types | trial-use | 2 | oo | 2025-01 | uv | hl7 | loinc |
hl7.fhir.eu.laboratory | R4 | lab-studyType-eu-lab | Laboratory Study Types | trial-use | 2 | 2025-07 | eu | hl7 | loinc | |
hl7.fhir.uv.lab-report | R4 | obsCode-loinc-uv-lab | Laboratory Code: LOINC | trial-use | 2 | oo | 2025-01 | uv | hl7 | loinc |
hl7.fhir.eu.laboratory | R4 | lab-obsCode-loinc-eu-lab | Laboratory Code: LOINC | trial-use | 2 | 2025-07 | eu | hl7 | loinc | |
hl7.fhir.uv.lab-report | R4 | obsCode-npu-uv-lab | Laboratory Code: NPU | trial-use | 2 | oo | 2025-01 | uv | hl7 | |
hl7.fhir.eu.laboratory | R4 | lab-obsCode-npu-eu-lab | Laboratory Code: NPU | trial-use | 2 | 2025-07 | eu | hl7 | ||
hl7.fhir.uv.lab-report | R4 | obsCode-uv-lab | Laboratory Code | trial-use | 2 | oo | 2025-01 | uv | hl7 | fhir |
hl7.fhir.eu.laboratory | R4 | lab-obsCode-eu-lab | Laboratory Code | trial-use | 2 | 2025-07 | eu | hl7 | internal | |
hl7.fhir.us.breastcancer | R3 | oncology-HER2byFISHVSInterpretationTestsVS | BC HER2byFISHVSInterpretationTestsVS ValueSet | draft | 2018-08 | us | hl7 | loinc | ||
hl7.fhir.us.breastcancer | R3 | oncology-EstrogenReceptorInterpretationTestsVS | BC EstrogenReceptorInterpretationTestsVS ValueSet | draft | 2018-08 | us | hl7 | loinc | ||
hl7.fhir.us.breastcancer | R3 | oncology-HER2byIHCInterpretationTestsVS | BC HER2byIHCInterpretationTestsVS ValueSet | draft | 2018-08 | us | hl7 | loinc | ||
hl7.fhir.us.breastcancer | R3 | oncology-ProgesteroneReceptorInterpretationTestsVS | BC ProgesteroneReceptorInterpretationTestsVS ValueSet | draft | 2018-08 | us | hl7 | loinc | ||
hl7.fhir.uv.lab-report | R4 | technique-uv-lab | Laboratory Techniques | trial-use | 2 | oo | 2025-01 | uv | hl7 | sct |
hl7.fhir.cz.lab | R4 | cz-lab-technique-vs | Laboratory Techniques | trial-use | 2 | 2025-07 | cz | hl7 | sct | |
hl7.fhir.eu.laboratory | R4 | lab-technique-eu-lab | Laboratory Techniques | trial-use | 2 | 2025-07 | eu | hl7 | sct | |
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1003 | Observation Method | active | 2008-01 | us | tho | |||
hl7.eu.fhir.idea4rc | R4 | pos-neg-nt-athena-eu-i4rc | Positive-Negative-No Test: Athena | active | 2025-07 | eu | hl7 | |||
hl7.eu.fhir.idea4rc | R4 | yes-no-unk-athena-eu-i4rc | Yes-No-Unk: Athena | active | 2025-07 | eu | hl7 | |||
de.gecco | R4 | gecco-valueset-laboratory-tests | Laboratory Tests GECCO | active | loinc | |||||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8037 | Test Type (Brucellosis) | active | 2021-01 | us | sct tho oid | |||
de.medizininformatikinitiative.kerndatensatz.laborbefund | R4 | mii-vs-labor-laborbereich | MII VS Labor Laborbereich | active | 2023-12 | de | tho loinc | |||
hl7.terminology | R5 | v3-LacrimalPunctaRoute | LacrimalPunctaRoute | active | 2014-03 | uv | hl7 | tho | ||
smart.who.int.ips-pilgrimage | R4 | Language | Language | draft | 2025-05 | who | internal | |||
nictiz.fhir.nl.stu3.geboortezorg | R3 | 2.16.840.1.113883.2.4.11.141--20130320000000 | Language Ability Proficiency | active | nl | fhir | ||||
synapxe.rcm.snapshots | R5 | rcm-language | RCM Language | active | 2024-08 | fhir | ||||
healthdata.be.r4.cbb | R4 | LanguageControlListening | LanguageControlListening | draft | tho | |||||
healthdata.be.r4.cbb | R4 | LanguageControlReading | LanguageControlReading | draft | tho | |||||
healthdata.be.r4.cbb | R4 | LanguageControlSpeaking | LanguageControlSpeaking | draft | tho | |||||
laniado.test.fhir.r4 | R4 | k-safa | k-safa | draft | ||||||
ca.on.oh.mha-pds | R4 | Language | Language | active | 2022-08 | ca | hl7 | tho ietf | ||
ca.infoway.io.erec | R4 | human-language | Human Language | draft | national | ietf | ||||
ca.infoway.io.erec | R4 | preference-type | Preference Type Code | draft | national | |||||
PCR.R4.1-1-0-pkg | R4 | Language | Language | active | ietf | |||||
hl7.eu.fhir.unicom | R5 | language-ema-vs | EMA SPOR Language | draft | 2025-06 | eu | hl7 | |||
ans.fr.nos | R4 | JDV-J115-Langue-ENREG | JDV_J115-Langue-ENREG | active | 2024-09 | fr | national | |||
ans.fr.nos | R4 | JDV-J82-Langue-RASS | JDV_J82-Langue-RASS | active | 2024-09 | fr | national | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3097 | Present Absent Unknown Not Examined | active | 2008-01 | us | sct tho | |||
hl7.terminology | R5 | v3-LaryngealRoute | LaryngealRoute | active | 2014-03 | uv | hl7 | tho | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7612 | Late Clinical Manifestation (STD) | active | 2021-01 | us | tho oid | |||
cce.fhir.minimal | R4 | ValueSet-cce-core-ValueSet-TumorSiteLocationVS | Tumor Site Location VS | draft | ||||||
cce.fhir | R4 | ValueSet-cce-core-ValueSet-SitelocationVS | SitelocationVS | draft | ||||||
nictiz.fhir.nl.stu3.geboortezorg | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.20.7.2--20200901000000 | LateraliteitCodelijst | active | nl | sct | ||||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.20.2--20200901000000 | LateraliteitCodelijst | active | nl | hl7 | sct | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.12--20171231000000 | LateraliteitCodelijst | active | nl | hl7 | sct | |||
hl7.fhir.be.core-clinical | R4 | be-vs-laterality | Laterality | active | 1 | 2021-01 | be | hl7 | sct | |
ehealthplatform.be.r4.federalprofiles | R4 | be-vs-laterality | Laterality | active | 2021-01 | hl7 | fhir | |||
hl7.cda.uv.ips | R4 | 2.16.840.1.113883.11.22.57--20171212192725 | Laterality (qualifier) | draft | 2024-08 | uv | hl7 | sct | ||
healthdata.be.r4.cbb | R4 | Laterality | Laterality | draft | sct | |||||
silfhirprofileig | R5 | sghi-laterality | Laterality Value Sets | active | 2025-07 | internal | ||||
ch.fhir.ig.ch-crl | R4 | nkrs-icdo3laterality | NKRS - ICD-O-3 Laterality | active | 2022-02 | ch | hl7 | internal | ||
nr.gp.leumit | R4 | vs-body-site-laterality | Body Site Laterality | draft | 2025-03 | il | sct | |||
hl7.terminology | R5 | v3-LavageRoute | LavageRoute | active | 2014-03 | uv | hl7 | tho | ||
dk.kip.rkkp.fhir.ig.core | R4 | LedbaandsrekonstruktionDKRR | Ledbåndsrekonstruktioner (DKRR) | active | 2022-09 | internal | ||||
ca.on.oh.corhealth | R4 | CorHealth52LeftVentricularEjectionFractionGradeVS | Left Ventricular Ejection Fraction Grade | active | ||||||
dk.kip.rkkp.fhir.ig.core | R4 | LeftRight | Left or right | active | 2022-07 | tho | ||||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.883 | PHIN Questions | active | 2013-01 | us | oid | |||
hl7.org.nz.fhir.ig.formulary | R4B | medicine-classification-code | Legal Medication status | active | 2025-08 | nz | hl7 | |||
tewhatuora.hip-core | R4 | hpi-legal-entity-type-1.0 | Legal Entity Type | retired | 2020-02 | national | ||||
signal.core.r4 | R4 | questionnaire-ccars-legal-status | Questionnaire CCARS Legal Status | draft | 1 | pa | us | hl7 | ||
healthdata.be.r4.cbb | R4 | LegalStatus | LegalStatus | draft | oid | |||||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7714 | Legionella Diagnosis (RIBD) | active | 2018-01 | us | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7715 | Legionella Exposure (RIBD) | active | 2018-01 | us | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7737 | Legionellosis Serogroup (RIBD) | active | 2018-01 | us | sct tho oid | |||
kbv.ita.aws | R4 | KBV_VS_AW_Leistungsart | KBV_VS_AW_Leistungsart | active | 2018-10 | |||||
de.gkvsv.erezeptabrechnungsdaten | R4 | GKVSV-VS-ERP-Leistungserbringer-Sitz | GKVSV_VS_ERP_Leistungserbringer_Sitz | active | 2024-02 | |||||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7770 | Length of Time Drug Taken (TB) | active | 2018-01 | us | sct oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7468 | Length of Gestation in Weeks | active | 2016-01 | us | sct | |||
ans.fhir.fr.eclaire | R4 | eclaire-status-recruitment-vs | Statut de recrutement Value Set | draft | 2024-02 | fr | national | internal | ||
ans.fr.nos | R4 | JDV-J264-ModeEtCentreDePriseEnCharge-MDPH | JDV_J264-ModeEtCentreDePriseEnCharge-MDPH | active | 2024-06 | fr | national | |||
ca.on.oh.corhealth | R4 | CorHealth127LesionLocationVS | Lesion Location | active | ||||||
hl7.fhir.us.registry-protocols | R4 | LesionSegmentNumber | Lesion Segment Number | active | cic | 2023-11 | us | hl7 | fhir sct | |
ca.on.oh.corhealth | R4 | CorHealth128LesionTypeVS | Lesion Type | active | ||||||
dk.kip.rkkp.fhir.ig.core | R4 | PatobankSNOMEDLeukemiaDiagnose | Leukæmi diagnoser | active | 2022-06 | internal | ||||
nr.gp.leumit | R4 | visit-expertise | Visit Expertise Codes | draft | il | |||||
nr.gp.leumit | R4 | encounter-type | Leumit encounter types | draft | il | |||||
ihe.pcc.mpsc | R4 | Level.Of.Responsiveness.AVPU.VS | Level Of Responsiveness AVPU Value Set | draft | 2025-03 | uv | ihe | sct | ||
caseworks.mhaie002 | R4 | vs-EducationLevel | EducationLevelValueSet | active | ||||||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.921 | Emergency Department Acuity | active | 2008-01 | us | tho oid | |||
hl7.fhir.us.mcode | R4 | mcode-clark-level-value-vs | Clark Level Value Set | active | cic | 2025-02 | us | hl7 | sct | |
nictiz.fhir.nl.stu3.geboortezorg | R3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.207--20201112144120 | Leven voelen | active | nl | sct | ||||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.7.5.1--20200901000000 | LevensovertuigingCodelijst | active | nl | hl7 | sct tho oid | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.7.5.1--20171231000000 | LevensovertuigingCodelijst | active | nl | hl7 | fhir sct oid | |||
smart.who.int.ips-pilgrimage | R4 | LicensingModel | Licensing Model | draft | 2025-05 | who | internal | |||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.12.5--20200901000000 | LichaamsbewegingCodelijst | active | nl | hl7 | oid | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.12.5--20171231000000 | LichaamsbewegingCodelijst | active | nl | hl7 | oid | |||
rapportendoscopiequebec.test | R4 | ca-qc-endo-valueset-lienusagerendo | LienUsagerEndo | active | 2024-05 | sct | ||||
RapportEndoscopieQuebec.test | R4 | ca-qc-endo-valueset-lienUsagerEndo | LienUsagerEndo | active | 2023-09 | sct | ||||
ans.fr.nos | R4 | JDV-J235-LieuFormation-EPARS | JDV_J235-LieuFormation-EPARS | active | 2024-07 | fr | national | |||
healthdata.be.r4.cbb | R4 | LifeStance | LifeStance | draft | sct tho oid | |||||
signal.core.r4 | R4 | questionnaire-answers-status | QuestionnaireResponseStatus | draft | 3 | fhir | 2019-10 | us | hl7 | fhir |
nictiz.fhir.nl.stu3.geboortezorg | R3 | 2.16.840.1.113883.2.4.11.188--20140102000000 | Ligging | active | nl | fhir sct | ||||
nictiz.fhir.nl.stu3.geboortezorg | R3 | 2.16.840.1.113883.2.4.11.177--20131224000000 | LiggingBijGeboorte22 | active | nl | fhir sct | ||||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.10.2.3--20171231000000 | LijnStatusCodelijst | active | nl | hl7 | fhir oid | |||
hl7.fhir.us.mcode | R4 | mcode-tnm-distant-metastases-staging-type-max-vs | TNM Distant Metastases Staging Type Maximum Value Set | active | 4 | cic | 2025-02 | us | hl7 | fhir loinc |
hl7.fhir.us.mcode | R4 | mcode-tnm-primary-tumor-staging-type-max-vs | TNM Primary Tumor Staging Type Maximum Value Set | active | 4 | cic | 2025-02 | us | hl7 | fhir loinc |
hl7.fhir.us.mcode | R4 | mcode-tnm-regional-nodes-staging-type-max-vs | TNM Regional Nodes Staging Type Maximum Value Set | active | 4 | cic | 2025-02 | us | hl7 | fhir loinc |
hl7.fhir.us.mcode | R4 | mcode-tnm-stage-group-staging-type-max-vs | TNM Stage Group Staging Type Maximum Value Set | active | 4 | cic | 2025-02 | us | hl7 | fhir loinc |
hl7.fhir.us.mcode | R4 | mcode-condition-status-trend-max-vs | Condition Status Trend Maximum Value Set | active | 3 | cic | 2025-02 | us | hl7 | fhir sct |
kl.dk.fhir.children | R4 | ParentTypes | ForælderTyper | active | 2024-10 | dk | tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.941 | Susceptibility Result | active | 2008-01 | us | sct tho oid | |||
dk.kip.rkkp.fhir.ig.core | R4 | LimnavnDHDB | Limnavn (DHDB) | active | 2022-07 | internal | ||||
healthdata.be.r4.cbb | R4 | LineStatus | LineStatus | draft | tho oid | |||||
dk.kip.rkkp.fhir.ig.core | R4 | LinerCrosslinkedDHR | Liner - Crosslinked (DHR) | active | 2022-11 | internal | ||||
dk.kip.rkkp.fhir.ig.core | R4 | LinerMedPostDKR | Liner komponent med Post (DKR) | active | 2023-12 | internal | ||||
dk.kip.rkkp.fhir.ig.core | R4 | LinerUdenPostDKR | Liner komponent uden Post (DKR) | active | 2023-12 | internal | ||||
dk.kip.rkkp.fhir.ig.core | R4 | LinertypeDHR | Linertype - (DHR) | active | 2022-11 | internal | ||||
hl7.terminology | R5 | v3-LingualRoute | LingualRoute | active | 2014-03 | uv | hl7 | tho | ||
hl7.terminology | R5 | v3-RoleClassPersonalRelationship | RoleClassPersonalRelationship | active | 2014-03 | uv | hl7 | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.636 | Lp(a) Test_CPT | active | 2025-03 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.637 | LP(a) Test | active | 2025-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.634 | Lp(a) Test_LOINC | active | 2025-03 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.633 | Lp(a) Test_SNOMED | active | 2025-03 | us | hl7 | sct | ||
ca.on.health.idms | R5 | IDMS-ValueSet-Letter-Types-ACTIVE | Letter Types (Active Only) | active | 2025-01 | |||||
ca.on.health.idms | R5 | VALUESET-PACKAGE-TYPE-ACTIVE | Package Types (Active Only) | active | 2025-01 | |||||
hl7.fhir.uv.radiation-dose-summary | R4 | isotope-rds-vs | Isotopes Value Set | trial-use | 2 | ii | 2025-05 | uv | hl7 | dcm |
ca.on.health.idms | R5 | IDMS-VALUESET-AUDIT-ENTITY-TYPE | Audit Entity Type | active | 2025-01 | |||||
ca.on.health.idms | R5 | 064df573-b528-420c-8935-5b70fd731511 | Authorization Roles | active | 2025-01 | |||||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3241 | Notifiable Event Condition (Flu) | active | 2009-01 | us | oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3594 | Campylobacter Organism | active | 2010-01 | us | sct | |||
ca.on.health.idms | R5 | 5bce5e52-9a9b-4483-9430-cf83f61b8929 | Child Request Types | active | 2025-01 | |||||
ca.on.health.idms | R5 | IDMS-VALUESET-COMMITTEE-RECOMMENDATION-NEW | Committee Recommendation - New | active | 2025-01 | |||||
ca.on.health.idms | R5 | IDMS-VALUESET-COMMITTEE-RECOMMENDATION | Committee Recommendation | active | 2025-01 | |||||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.988 | Countermeasure Encounter Purpose | active | 2008-01 | us | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.989 | Countermeasure Encounter Type | active | 2008-01 | us | tho | |||
hl7.fhir.us.resp-net | R4 | resp-net-labtest-covid-codes | resp-net-labtest-covid-codes | draft | 2025-08 | us | hl7 | cpt loinc | ||
ca.on.health.idms | R5 | IDMS-VALUESET-CROSS-REFERENCE-TYPE | Cross Reference Type | active | 2025-01 | |||||
ca.on.health.idms | R5 | VALUESET-DOCUMENT-REFERENCE-LETTER-TYPES | DocumentReference Letter Types | active | 2025-01 | |||||
ca.on.health.idms | R5 | 9ce0265f-05f2-4ca4-88d9-4f13ae2a67a9 | Document Reference Types | active | 2025-01 | |||||
ca.on.health.idms | R5 | IDMS-VALUESET-DRUG-CHARACTERISTIC | Drug Characteristics | active | 2024-01 | |||||
ca.on.health.idms | R5 | IDMS-VALUESET-DRUG-REVIEW-PATHWAY | Drug Review Pathways | active | 2027-01 | |||||
hl7.fhir.us.resp-net | R4 | resp-net-labtest-flu-codes | resp-net-labtest-flu-codes | draft | 2025-08 | us | hl7 | cpt loinc | ||
hl7.fhir.us.resp-net | R4 | resp-net-labtest-flu-rsv-covid-codes | resp-net-labtest-flu-rsv-covid-codes | draft | 2025-08 | us | hl7 | cpt loinc | ||
ca.on.health.idms | R5 | IDMS-ValueSet-FUNDING-PROGRAM | Funding Program | active | 2025-07 | |||||
ch.fhir.ig.ch-ems | R4 | IVR-VS-gcs-augenoeffnung | IVR GCS Eye Opening | draft | 2025-08 | ch | hl7 | internal sct | ||
ch.fhir.ig.ch-ems | R4 | IVR-VS-gcsMotoric | IVR GCS Motoric Response | draft | 2025-08 | ch | hl7 | internal sct | ||
ch.fhir.ig.ch-ems | R4 | IVR-VS-gcsVerbal | IVR GCS Verbal Response | draft | 2025-08 | ch | hl7 | internal sct | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.6047 | Message Structure (Syndromic Surveillance) | active | 2019-01 | us | tho | |||
ca.on.health.idms | R5 | IDMS-VALUESET-INDIVIDUAL-REVIEW-EXPERTISE | Reviewer Expertise | active | 2025-01 | |||||
hl7.fhir.uv.lab-report | R4 | orderCodes-uv-lab | Laboratory Order | trial-use | 2 | oo | 2025-01 | uv | hl7 | loinc |
hl7.fhir.eu.laboratory | R4 | lab-orderCodes-eu-lab | Laboratory Order | trial-use | 2 | 2025-07 | eu | hl7 | fhir loinc | |
ca.on.health.idms | R5 | IDMS-ValueSet-Letter-Types | Letter Types | active | 2025-01 | |||||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3244 | Medication Treatment (Flu) | active | 2009-01 | us | tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1073 | Microbiology Test Result Name | active | 2008-01 | us | loinc | |||
ch.fhir.ig.ch-ems | R4 | IVR-VS-NACA | IVR NACA | draft | 2025-08 | ch | hl7 | internal | ||
ca.on.health.idms | R5 | IDMS-VALUESET-NAME-PREFIX | Name Prefixes | active | 2025-01 | |||||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1107 | Notification Section Header | active | 2015-01 | us | oid loinc | |||
ca.on.health.idms | R5 | ORGANIZATION-TYPE-ALL | Organization Types - All | active | 2025-01 | |||||
ca.on.health.idms | R5 | b6968639-cb27-4258-aad4-e4580577686d | Organization Types - Subset | active | 2025-01 | |||||
ca.on.health.idms | R5 | VALUESET-PACKAGE-TYPE | Package Types | active | 2025-01 | |||||
ca.on.health.idms | R5 | IDMS-VALUESET-PRODUCT-IDENTIFIER-TYPE | Product Identifier Types | active | 2025-01 | |||||
ca.on.health.idms | R5 | IDMS-Product-Types | Product Types | active | 2025-01 | |||||
ca.on.health.idms | R5 | 9350b300-3e5f-4315-bb2a-4aa999748900 | Questionaires | active | 2029-08 |